Log in to save to my catalogue

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability...

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A616354516

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel[R] in the treatment of irritable bowel syndrome with diarrhoea in adults

About this item

Full title

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel[R] in the treatment of irritable bowel syndrome with diarrhoea in adults

Publisher

BioMed Central Ltd

Journal title

Trials, 2020, Vol.21 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Irritable bowel syndrome (IBS) with diarrhoea (IBS-D) is a common and chronic condition that can significantly impair quality of life. The emergence of new drugs for IBS-D has been slow and there is a need for new treatments, including drug-free treatments, which are easy to use and suitable for different patient groups. Currently available drug-fr...

Alternative Titles

Full title

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel[R] in the treatment of irritable bowel syndrome with diarrhoea in adults

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A616354516

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A616354516

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-020-4069-x

How to access this item